Human T-lymphotropic virus type

Muesing MA, Smith DH, Capon DJ (1987) Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. CeU 48(4) 691-701 Nicholson JK, Cross GD, CaUaway CS, McDougal JS (1986) In vitro infection of human monocytes with human T lymphotropic virus type Ill/lymphadenopathy-associated virus (HTLV-III/ LAV). J Immunol 137(l) 323-329... 

Harper, M. E., Marselle, L. M., Gallo, R. C., andWong-Stahl, F. (1986) Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83, 772-776. 

Martin, L.S., J.S. McDougal, and S.L. Loskoski. 1985. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 152 400. 

Moritoyo T, Reinhart TA, Moritoyo H, Sato E, Izumo S, Osame M, Haase AT (1996) Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4-t- T lymphocytes. Ann Neurol 40 84-90. 

Nakamura T, Fumya T, Nishiura Y, Ichinose K, Shirabe S, Eguchi K (2000) Importance of immune deviation toward Thl in the early immunopathogenesis of human T-lymphotropic virus type I-associated myelopathy. Med Hypotheses 54 777—782. 

Gessain A, Batin F, Vemant JC, Gout O, Maurs L, Calender A, de The G (1985) Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2 407-410. 

Hanon E, Goon P, Taylor GP, Hasegawa H, Tanaka Y, Weber JN, Bangham CR (2001) High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells. Blood 98 721-726. 

Y Ichinohe T, Tsunetsugu-Yokota Y, Katano H, Takahashi H, Matsuda J, Sata T, Kurata T, Nagashima K, HaU WW (2006) Thymus-derived leukemia-lymphoma in mice transgenic for the Tax gene of human T-lymphotropic virus type I. Nat Med 12 466 72. 

Kubota R, Kawanishi T, Matsubara H, Manns A, Jacobson S (1998) Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8-I- lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection. J Immunol 161 482-488. 

Lairmore MD, Silverman L, Ratner L (2005) Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation. Oncogene 24 6005-6015. 

Levin MC, Lee SM, Morcos Y, Brady J, Stuart J (2002a) Crossreactivity between immunodominant human T lymphotropic virus type I tax and neurons Implications for molecular mimicry. J Infect Dis 186 1514—1517. 

Yamada S, Ikeda H, Yamazaki H, Shikishima H, Kikuchi K, Wakisaka A, Kasai N, Shimotohno K, Yoshiki T (1995) Cytokine-producing mammary carcinomas in transgenic rats carrying the pX gene of human T-lymphotropic virus type I. Cancer Res 55 2524—2527. 

Centers for Disease Control (CDC). Recommendations for preventing transmission of infection with human T-lymphotropic virus type Ill/lymphadenopathy-associated virus in the workplace. MMWR Morb Mortal Wkly Rep 1985 34(45) 681-6,691-5. 

The efficacy and adverse effects of ivermectin 200 micro-grams/kg, repeated 2 weeks later, have been stndied in 50 patients with chronic strongyloidiasis, aged 30-79 years (13). The eradication rate was 96% at 2 weeks after the first dose and 98% after the second dose. There was no recurrence after follow-up of 4 months. One patient had nausea and vomiting 3 hours after the first dose and again after the second dose, but they were transient and required no therapy. In four patients there were mild laboratory abnormalities (slight increases in liver function tests in two, microscopic hematuria in one, and mild leukopenia and lymphocytosis in one). Of the 50 patients 12 were positive for human T lymphotropic virus type-I. 

Vrang, L. and Oberg, B. (1986) PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. Antimicrob. Agents Chemother. 29, 867-872. 

Mitsuya H, Weinhold KJ, Furman PA, et al. 3 -Azido-3 -deoxythymidine (BW A509U) an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type lll/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci U S A 1985 82 7096-7100. 

Frangione-Beebe M, Albrecht B, Dakappagari N, Rose RT, Brooks CL, Schwendeman SP, Lairmore MD, Kamnaya PT. Enhanced immunogenicity of a conformational epitope of human T-lymphotropic virus type 1 using a novel chimeric peptide. Vaccine 2000 19 1068-1081. 

By comparison to the Gln-40 to Phe-43 region of the X-ray crystal structure, the mimetic portion of 49 showed good structural similarity to CD4. Interestingly, this mimetic both inhibits binding of human T-lymphotropic virus type IIIB gpl20 to CD4 in a concentration-dependent manner and reduces syncytium formation. The for this CD4 mimetic was estimated to be between 4 and 20 p,M. 

V. C. W. Tsang, K. Hancock, M. Wilson. Enzyme-linked Immunotransfer Blot Technique for Human T-lymphotropic Virus Type III/Lymphoadenopathy Associated Virus (HTLVIII/LAV) Antibodies, in Immunology Series... 

Moriuchi H, Moriuchi M, Fauci AS. Factors secreted by human T lymphotropic virus type I (HTLV-I)-infected cells can enhance or inhibit replication of HIV-1 in HTLV-I-uninfected cells implications for in vivo coinfection with HTLV-I and HIV-1. J Exp Med 1998 187 1689-1697. 

Hakre S, Manak MM, Murray CK, Etavis KW, Bose M, Harding AJ, et al. Transfusion-transmitted human T-lymphotropic virus Type 1 infection in a United States military emergency whole blood transfusion recipient in Afghanistan, 2010. Transfusion 2013 53(10) 2176-82. 

Saito M, Higuchi I, Saito A et al. (2002) Molecular analysis of T cell clonotypes in muscle-infiltrating lymphocytes from patients with human T lymphotropic virus type 1 polymyositis. J Infect Dis 186, 1231-1241. 

Weinberg, J.B., D.L. Blazey, T.J. Matthews, B.F. Haynes, T.J. Palker, R.A. Spiegel, R.A. Meriwether, J.N. MacCormack, M. Robert-Guroff, and M. Popovic. 1987. Adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus type I (HTLV-I) infection—North Carolina. Morbid. Mortal. Weekly Rep. 36 804-806, 812. 

Human immunodeficiency virus (human T-lymphotropic virus type Ill/lymph-adenopathy-associated virus)—AIDS agent (325, 489). 

Oka T, Iwata J, Furihata M, Sonobe H, Miyoshi I, Ohtsuki Y (1992). Inhibitory effects of human interferons on the immortalization of human, but not rabbit, T lymphocytes by human T-lymphotropic virus type-1 (HTLV-I). 

---